Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04468932 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy
A NA study of Palsy Supranuclear and Supranuclear Palsy, Progressive, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04468932 is a NA study of Palsy Supranuclear and Supranuclear Palsy, Progressive that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04468932, a NA study of Palsy Supranuclear and Supranuclear Palsy, Progressive, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural instability in patients with PSP. We will use functional near infrared spectroscopy (fNIRS) to examine changes in motor and premotor cortical activity after cerebellar rTMS.
Conditions Studied
Interventions
- DEVICE Repetitive transcranial magnetic stimulation (rTMS)
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-01-17 |
| Est. Completion | 2027-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04468932
The ClinicalTrials.gov registry entry for NCT04468932 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Palsy Supranuclear appearing as the primary indexed condition, and to 1 intervention - of which Repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT04468932 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT04468932 about?
NCT04468932 is a clinical study titled "Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy". The objective of this proposal is to investigate the effect of non-invasive repetitive cerebellar transcranial magnetic stimulation (rTMS) on motor control in progressive supranuclear (PSP). The central hypothesis is that augmenting cerebellar inhibition via cerebellar rTMS will decrease postural in...
What is the current status of trial NCT04468932?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2020-01-17. Estimated completion is 2027-04-20.
What conditions does trial NCT04468932 study?
This clinical trial studies the following conditions: Palsy Supranuclear, Supranuclear Palsy, Progressive.
What interventions are being tested in trial NCT04468932?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT04468932?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04468932 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.